News for Evelo Biosciences, Inc. (EVLO)

Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Appointment of John Hohneker, M.D. Resignation of Chidozie Ugwumba PHILADELPHIA, April 1, 2024 /PRNewswire/ -- Carisma Therapeutics Inc.  , a clinical-stage biopharmaceutical company focused on...

- Fourth Quarter 2023 Net Investment Income per Share of $0.45; NAV per Share of $9.71 - - Annual Debt Portfolio Yield of 16.6% - - HRZN Ends Year with Committed Backlog of $218 Million - - Declares...

Seres Therapeutics appoints new CFO as Arkowitz retires

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc....

Evelo Biosciences, Inc. dropped from S&P TMI Index...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,323.77 while the NASDAQ fell 0.13% to 14,247.68. The S&P 500 also fell, dropping, 0.02% to 4,555.53.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.01%

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

On October 31, 2023, FMR LLC (Trades, Portfolio), a prominent investment firm, made a significant adjustment to its portfolio by reducing its holdings in Evelo

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.07%

Companies covered in this report are Seres Therapeutics, Inc., Microbiotica, Enterome, Destiny Pharma plc, Taisho Pharmaceutical Holdings, AOBiome...

U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow trade...

U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,275.55 while the NASDAQ rose 0.52% to 14,135.92. The S&P 500, also rose, gaining, 0.32% to 4,549.47.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06%

/PRNewswire/ -- The "Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

/PRNewswire/ -- DelveInsight's 'Asthma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline asthma...

/PRNewswire/ -- The microbiomes market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 21.95% and register an...

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Live Biotherapeutic Product (LBP) Market...